- Home
- AFJK vs BAFN Comparison
AFJK vs BAFN Comparison
Compare AFJK & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFJK
- BAFN
- Stock Information
- Founded
- AFJK 2023
- BAFN 1999
- Country
- AFJK United States
- BAFN United States
- Employees
- AFJK N/A
- BAFN N/A
- Industry
- AFJK
- BAFN Savings Institutions
- Sector
- AFJK
- BAFN Finance
- Exchange
- AFJK NYSE
- BAFN Nasdaq
- Market Cap
- AFJK 67.0M
- BAFN 70.2M
- IPO Year
- AFJK 2023
- BAFN N/A
- Fundamental
- Price
- AFJK $10.99
- BAFN $14.10
- Analyst Decision
- AFJK
- BAFN
- Analyst Count
- AFJK 0
- BAFN 0
- Target Price
- AFJK N/A
- BAFN N/A
- AVG Volume (30 Days)
- AFJK 4.1K
- BAFN 11.1K
- Earning Date
- AFJK 01-01-0001
- BAFN 04-24-2025
- Dividend Yield
- AFJK N/A
- BAFN 2.28%
- EPS Growth
- AFJK N/A
- BAFN 134.31
- EPS
- AFJK 0.28
- BAFN 2.62
- Revenue
- AFJK N/A
- BAFN $83,769,000.00
- Revenue This Year
- AFJK N/A
- BAFN N/A
- Revenue Next Year
- AFJK N/A
- BAFN N/A
- P/E Ratio
- AFJK $38.87
- BAFN $5.35
- Revenue Growth
- AFJK N/A
- BAFN 10.60
- 52 Week Low
- AFJK $10.24
- BAFN $10.40
- 52 Week High
- AFJK $11.01
- BAFN $19.75
- Technical
- Relative Strength Index (RSI)
- AFJK N/A
- BAFN 35.32
- Support Level
- AFJK N/A
- BAFN $13.00
- Resistance Level
- AFJK N/A
- BAFN $14.25
- Average True Range (ATR)
- AFJK 0.00
- BAFN 1.16
- MACD
- AFJK 0.00
- BAFN -0.23
- Stochastic Oscillator
- AFJK 0.00
- BAFN 20.75
About AFJK AIMEI HEALTH TECHNOLOGY CO LTD
Aimei Health Technology Co Ltd is a blank check company.
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a one bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios.